Results 341 to 350 of about 738,525 (387)

Evaluation of early treatment with intravenous idursulfase and intrathecal idursulfase‐IT on cognitive function in siblings with neuronopathic mucopolysaccharidosis II

Journal of Inherited Metabolic Disease, EarlyView.
Abstract Mucopolysaccharidosis II (MPS II; Hunter syndrome; OMIM 309900) is a rare, X‐linked, heterogeneous lysosomal storage disease. Approximately two‐thirds of patients develop cognitive impairment, which is difficult to assess in clinical trials, partly owing to the variable nature of cognitive impairment.
Joseph Muenzer, Barbara K. Burton, Paul Harmatz, Luis González Gutiérrez‐Solana, Matilde Ruiz‐Garcia, Simon A. Jones, Nathalie Guffon, Michal Inbar‐Feigenberg, Drago Bratkovic, Stewart Rust, Michael Hale, Yuna Wu, Karen S. Yee, David A. H. Whiteman, David Alexanderian   +14 more
wiley   +1 more source

Imaging Assessment of the Pituitary Gland and Long‐Term Endocrinological Abnormalities in Pediatric Brain Cancer Survivors

Journal of Magnetic Resonance Imaging, EarlyView.
Background Pediatric brain cancer survivors often experience hypothalamic–pituitary dysfunction due to cranial irradiation and chemotherapy. While hormone deficiencies have been studied, the changes in pituitary size and shape on long‐term MRI and their relationship to endocrine dysfunction remain under‐explored.
Feras Qawasmi, Maria Segev, Tamer Sobeh, Larisa Gorenstein, Gadi Abebe‐Campino, Chen Hoffmann, Michal Yalon, Dalit Modan‐Moses, Shai Shrot   +8 more
wiley   +1 more source

The Relationship Between the Percent Coefficient of Variation of Sensor Glucose Levels and the Risk of Severe Hypoglycemia or Non-Severe Hypoglycemia in Patients With Type 1 Diabetes: Post Hoc Analysis of the ISCHIA Study. [PDF]

J Diabetes Sci Technol
Murata T, Matsuhisa M, Kuroda A, Toyoda M, Hirota Y, Ogura M, Suzuki S, Kato K, Tone A, Matoba Y, Meguro S, Miura J, Nishimura K, Shimada A, Hosoda K, Sakane N, ISCHIA Study Group.   +16 more
europepmc   +1 more source

Identifying research priorities for pituitary adenoma surgery: an international Delphi consensus statement. [PDF]

Pituitary
Newall N, Valetopoulou A, Khan DZ, Borg A, Bouloux PMG, Bremner F, Buchfelder M, Cudlip S, Dorward N, Drake WM, Fernandez-Miranda JC, Fleseriu M, Geltzeiler M, Ginn J, Gurnell M, Harris S, Jaunmuktane Z, Korbonits M, Kosmin M, Koulouri O, Layard Horsfall H, Mamelak AN, Mannion R, McBride P, McCormack AI, Melmed S, Miszkiel KA, Raverot G, Santarius T, Schwartz TH, Serrano I, Zada G, Baldeweg SE, Kolias AG, Marcus HJ, PitCop Collaborative.   +35 more
europepmc   +1 more source

Artificial intelligence is going to transform the field of endocrinology: an overview. [PDF]

Front Endocrinol (Lausanne)
Belkhouribchia J.
europepmc   +1 more source

A successful remote patient monitoring program for diabetes. [PDF]

Front Endocrinol (Lausanne)
Sawyer K, Saxon D, Zane R, Patel H, McDermott M, Singh V, Lawler HM.   +6 more
europepmc   +1 more source

Characterization of 35 Novel NR5A1/SF-1 Variants Identified in Individuals With Atypical Sexual Development: The SF1next Study.

J Clin Endocrinol Metab
Naamneh Elzenaty R, Martinez de Lapiscina I, Kouri C, Sauter KS, Sommer G, Castaño L, Flück CE.   +6 more
europepmc   +1 more source

Correction to: "Tenascin-C Potentiates Wnt Signaling in Thyroid Cancer".

Endocrinology
europepmc   +1 more source

Dapagliflozin plus calorie restriction for remission of type 2 diabetes: multicentre, double blind, randomised, placebo controlled trial.

BMJ
Liu Y, Chen Y, Ma J, Lin J, Liu C, Li X, Xu Y, Kuang H, Shi L, Xue Y, Feng B, Zhu D, Wang G, Yang J, Xiao X, Yu X, Zhou J, Bao Y, Su Q, Lyu M, Li X, Zhang H, Li X.   +22 more
europepmc   +1 more source